{"schema":"rootz.ai/sec-company/v1","layer":0,"identity":{"name":"DiaMedica Therapeutics Inc.","cik":"0001401040","ticker":"DMAC","exchange":"Nasdaq","sic":"2834","sic_description":"Pharmaceutical Preparations","state_of_incorporation":"Z4","headquarters":null,"founded":null,"ipo_date":null,"status":"active"},"summary":"PART I Overview We are a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from severe ischemic disease with two main clinical programs focused on preeclampsia (PE) / fetal growth restriction (FGR) and acute ischemic stroke (AIS). Our lead candidate DM199 (rinvecalinase alfa), is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (rhKLK1) protein to be clinically studied in patients and has been granted Fast...","peak_metrics":{"market_cap_usd":null,"market_cap_date":null,"employees":null,"employees_date":null,"rd_spend_usd":null,"rd_spend_year":null},"tags":[],"deeper":{"profile":"/api/company/DMAC/profile","timeline":"/api/company/DMAC/timeline","filings":"/api/company/DMAC/filings","people":"/api/company/DMAC/people","skill":"/api/skills/DMAC","skill_json":"/api/skills/DMAC?format=json"},"data_freshness":{"latest_filing":"2026-08-10","latest_extracted":"2026-04-01","latest_quote":"2026-08-11","warning":"New filing(s) detected (2026-08-10) but not yet extracted. Latest extracted data is from 2026-04-01. Extraction runs 3x daily.","stale":true},"origin":{"leaf":"154b77ef40b30cd80cdaea708bf8be0b0d11ebc8cac314112cd96e606600f413","parent":"1b06acd9f7b2ba7304996032c49a4b0002fc22d7283676e27857fb5ec2ad0835","timestamp":"2026-08-26T20:18:30.441Z","source":"0001437749-26-010342","chain":"SEC.gov PEM > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Hash this response content + parent + timestamp to reproduce the leaf hash","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin chain (see origin.leaf) traceable to an SEC-signed source. It is UNVERIFIED until validated.","how_to_validate":"GET https://origin.rootz.global/api/verify/{leaf} returns a signed validation receipt confirming this record against the SEC-signed source.","chain":"SEC.gov filing (government signature) then origin.rootz.global extraction then this response.","licensing":"Reading is free. Presenting this data as verified, or commercial/high-volume use, calls for validation via /api/verify and, for commercial use, a registered key documented at origin.rootz.global/dashboard.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"unverified — GET https://origin.rootz.global/api/verify/{leaf} for a signed validation receipt before citing","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}